New drug halts growth of aggressive breast cancer in pre-clinical study

CDDD11-8 inhibits proliferation of patient-derived breast organoid models. Credit: Oncogene (2023). DOI: 10.1038/s41388-023-02892-3

A promising drug could lead to a new treatment for the most aggressive form of breast cancer, which affects thousands of women each year. A pre-clinical study led by the University of Adelaide found the new drug successfully inhibits the growth of triple negative breast cancer without any toxic side effects.

Continue Reading


News Source: medicalxpress.com


Posted

in

by

Tags: